pmc logo image
Logo of iaiInfect Immun SubscriptionsInfect Immun Web Site

Formats:

Infect Immun. 1993 February; 61(2): 781–784.
PMCID: PMC302795
Opsonization of Treponema pallidum is mediated by immunoglobulin G antibodies induced only by pathogenic treponemes.
J M Shaffer, S A Baker-Zander, and S A Lukehart
Department of Medicine, University of Washington, Seattle 98195.
Abstract
Rabbit antisera to Leptospira interrogans, Borrelia hermsii, and Treponema phagedenis biotype Reiter, reactive to shared spirochetal antigens, failed to enhance phagocytosis of Treponema pallidum by macrophages, while immunoglobulin G to Treponema pallidum subsp. pertenue and Treponema paraluiscuniculi promoted phagocytosis. Opsonic antibodies are directed to pathogen-restricted, not shared spirochetal, antigens.
Full text
Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (728K), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
  • Alder JD, Daugherty N, Harris ON, Liu H, Steiner BM, Schell RF. Phagocytosis of Treponema pallidum pertenue by hamster macrophages on membrane filters. J Infect Dis. 1989 Aug;160(2):289–297. [PubMed]
  • Alder JD, Friess L, Tengowski M, Schell RF. Phagocytosis of opsonized Treponema pallidum subsp. pallidum proceeds slowly. Infect Immun. 1990 May;58(5):1167–1173. [PubMed]
  • Alderete JF, Baseman JB. Surface-associated host proteins on virulent Treponema pallidum. Infect Immun. 1979 Dec;26(3):1048–1056. [PubMed]
  • Alderete JF, Baseman JB. Surface characterization of virulent Treponema pallidum. Infect Immun. 1980 Dec;30(3):814–823. [PubMed]
  • Al-Samarrai HT, Henderson WG. Immunity in syphilis. Studies in active immunity. Br J Vener Dis. 1976 Oct;52(5):300–308. [PubMed]
  • Baker-Zander SA, Hook EW, 3rd, Bonin P, Handsfield HH, Lukehart SA. Antigens of Treponema pallidum recognized by IgG and IgM antibodies during syphilis in humans. J Infect Dis. 1985 Feb;151(2):264–272. [PubMed]
  • Baker-Zander SA, Lukehart SA. Molecular basis of immunological cross-reactivity between Treponema pallidum and Treponema pertenue. Infect Immun. 1983 Nov;42(2):634–638. [PubMed]
  • Baker-Zander SA, Lukehart SA. Antigenic cross-reactivity between Treponema pallidum and other pathogenic members of the family Spirochaetaceae. Infect Immun. 1984 Oct;46(1):116–121. [PubMed]
  • Baker-Zander SA, Lukehart SA. Macrophage-mediated killing of opsonized Treponema pallidum. J Infect Dis. 1992 Jan;165(1):69–74. [PubMed]
  • Blanco DR, Walker EM, Haake DA, Champion CI, Miller JN, Lovett MA. Complement activation limits the rate of in vitro treponemicidal activity and correlates with antibody-mediated aggregation of Treponema pallidum rare outer membrane protein. J Immunol. 1990 Mar 1;144(5):1914–1921. [PubMed]
  • Champion CI, Miller JN, Borenstein LA, Lovett MA, Blanco DR. Immunization with Treponema pallidum endoflagella alters the course of experimental rabbit syphilis. Infect Immun. 1990 Sep;58(9):3158–3161. [PubMed]
  • CHRISTIANSEN S. Protective layer covering pathogenic treponemata. Lancet. 1963 Feb 23;1(7278):423–425. [PubMed]
  • Cox DL, Chang P, McDowall AW, Radolf JD. The outer membrane, not a coat of host proteins, limits antigenicity of virulent Treponema pallidum. Infect Immun. 1992 Mar;60(3):1076–1083. [PubMed]
  • Engelkens HJ, Kant M, Onvlee PC, Stolz E, van der Sluis JJ. Rapid in vitro immobilisation of purified Treponema pallidum (Nichols strain), and protection by extraction fluids from rabbit testes. Genitourin Med. 1990 Oct;66(5):367–373. [PubMed]
  • Fehniger TE, Walfield AM, Cunningham TM, Radolf JD, Miller JN, Lovett MA. Purification and characterization of a cloned protease-resistant Treponema pallidum-specific antigen. Infect Immun. 1984 Nov;46(2):598–607. [PubMed]
  • Fitzgerald TJ, Miller JN, Repesh LA, Rice M, Urquhart A. Binding of glycosaminoglycans to the surface of Treponema pallidum and subsequent effects on complement interactions between antigen and antibody. Genitourin Med. 1985 Feb;61(1):13–20. [PubMed]
  • Graves S. Sequential changes in susceptibility to Treponema pallidum of rabbits previously infected with Treponema paraluis-cuniculi. Br J Vener Dis. 1981 Feb;57(1):11–14. [PubMed]
  • Hindersson P, Petersen CS, Axelsen NH. Purified flagella from Treponema phagedenis biotype Reiter does not induce protective immunity against experimental syphilis in rabbits. Sex Transm Dis. 1985 Jul–Sep;12(3):124–127. [PubMed]
  • Hovind-Hougen K, Nielsen HA, Birch-Andersen A. Electron microscopy of treponemes subjected to the Treponema pallidum immobilization (TPI) test. I. Comparison of immunoimmobilized cells and control cells. Acta Pathol Microbiol Scand C. 1979 Jun;87C(3):217–222. [PubMed]
  • Hovind-Hougen K, Birch-Andersen A, Nielsen HA. Electron microscopy of treponemes subjected to the Treponema pallidum immobilization (TPI) test. II. Immunoelectron microscopy. Acta Pathol Microbiol Scand C. 1979 Aug;87C(4):263–268. [PubMed]
  • Izzat NN, Dacres WG, Knox JM, Wende R. Attempts at immunization against syphilis with avirulent Treponemma pallidum. Br J Vener Dis. 1970 Dec;46(6):451–453. [PubMed]
  • Jones SA, Marchitto KS, Miller JN, Norgard MV. Monoclonal antibody with hemagglutination, immobilization, and neutralization activities defines an immunodominant, 47,000 mol wt, surface-exposed immunogen of Treponema pallidum (Nichols). J Exp Med. 1984 Nov 1;160(5):1404–1420. [PubMed]
  • Lukehart SA, Baker-Zander SA, Gubish ER., Jr Identification of Treponema pallidum antigens: comparison with a nonpathogenic treponeme. J Immunol. 1982 Aug;129(2):833–838. [PubMed]
  • Lukehart SA, Baker-Zander SA, Lloyd RM, Sell S. Effect of cortisone administration on host-parasite relationships in early experimental syphilis. J Immunol. 1981 Oct;127(4):1361–1368. [PubMed]
  • Lukehart SA, Baker-Zander SA, Lloyd RM, Sell S. Characterization of lymphocyte responsiveness in early experimental syphilis. II. Nature of cellular infiltration and Treponema pallidum distribution in testicular lesions. J Immunol. 1980 Jan;124(1):461–467. [PubMed]
  • Lukehart SA, Miller JN. Demonstration of the in vitro phagocytosis of Treponema pallidum by rabbit peritoneal macrophages. J Immunol. 1978 Nov;121(5):2014–2024. [PubMed]
  • Marchitto KS, Jones SA, Schell RF, Holmans PL, Norgard MV. Monoclonal antibody analysis of specific antigenic similarities among pathogenic Treponema pallidum subspecies. Infect Immun. 1984 Sep;45(3):660–666. [PubMed]
  • Medici MA. The immunoprotective niche--a new pathogenic mechanism for syphilis, the systemic mycoses and other infectious diseases. J Theor Biol. 1972 Sep;36(3):617–625. [PubMed]
  • Miller JN. Immunity in experimental syphilis. VI. Successful vaccination of rabbits with Treponema pallidum, Nichols strain, attenuated by -irradiation. J Immunol. 1973 May;110(5):1206–1215. [PubMed]
  • Moskophidis M, Müller F. Monoclonal antibodies to immunodominant surface-exposed protein antigens of Treponema pallidum. Eur J Clin Microbiol. 1985 Oct;4(5):473–477. [PubMed]
  • Norris SJ, Sell S. Antigenic complexity of Treponema pallidum: antigenicity and surface localization of major polypeptides. J Immunol. 1984 Nov;133(5):2686–2692. [PubMed]
  • Penn CW. Avoidance of host defences by Treponema pallidum in situ and on extraction from infected rabbit testes. J Gen Microbiol. 1981 Sep;126(1):69–75. [PubMed]
  • Penn CW, Rhodes JG. Surface-associated antigens of Treponema pallidum concealed by an inert outer layer. Immunology. 1982 May;46(1):9–16. [PubMed]
  • Radolf JD, Fehniger TE, Silverblatt FJ, Miller JN, Lovett MA. The surface of virulent Treponema pallidum: resistance to antibody binding in the absence of complement and surface association of recombinant antigen 4D. Infect Immun. 1986 May;52(2):579–585. [PubMed]
  • Radolf JD, Norgard MV, Schulz WW. Outer membrane ultrastructure explains the limited antigenicity of virulent Treponema pallidum. Proc Natl Acad Sci U S A. 1989 Mar;86(6):2051–2055. [PubMed]
  • Schell RF, Azadegan AA, Nitskansky SG, LeFrock JL. Acquired resistance of hamsters to challenge with homologous and heterologous virulent treponemes. Infect Immun. 1982 Aug;37(2):617–621. [PubMed]
  • Stamm LV, Dallas WS, Ray PH, Bassford PJ., Jr Identification, cloning, and purification of protein antigens of Treponema pallidum. Rev Infect Dis. 1988 Jul–Aug;10 Suppl 2:S403–S407. [PubMed]
  • Strugnell RA, Handley CJ, Drummond L, Faine S, Lowther DA, Graves SR. Polyanions in syphilis: evidence that glycoproteins and macromolecules resembling glycosaminoglycans are synthesised by host tissues in response to infection with Treponema pallidum. Br J Vener Dis. 1984 Apr;60(2):75–82. [PubMed]
  • Strugnell RA, Handley CJ, Lowther DA, Faine S, Graves SR. Treponema pallidum does not synthesise in vitro a capsule containing glycosaminoglycans or proteoglycans. Br J Vener Dis. 1984 Feb;60(1):8–13. [PubMed]
  • van der Sluis JJ, Kant M, Onvlee PC, Stolz E. The inaccessibility of the outer membrane of adherent Treponema pallidum (Nichols strain) to anti-treponemal antibodies, a possible role of serum proteins. Genitourin Med. 1990 Jun;66(3):165–170. [PubMed]
  • Walker EM, Borenstein LA, Blanco DR, Miller JN, Lovett MA. Analysis of outer membrane ultrastructure of pathogenic Treponema and Borrelia species by freeze-fracture electron microscopy. J Bacteriol. 1991 Sep;173(17):5585–5588. [PubMed]
  • Wos SM, Wicher K. Antigenic evidence for host origin of exudative fluids in lesions of Treponema pallidum-infected rabbits. Infect Immun. 1985 Jan;47(1):228–233. [PubMed]